• Home
  • Contact
  • Sitemap
  • Approach
  • Imprint
tgcBIOMICS GmbH [EN]
  • About
    tgcBIOMICS
    • Our team
    • Advisory board and management
    • List of tgcBIOMICS Patents
    • NEWS & Press
      • Partners
      • Publications
    • Downloads
  • tgc-technology
    • Bacterial expression system
    • tgc technology
    • tgc bacteria
  • Our products
    • Antibodies
    • Toxins
    • Proteins
    • ELISA kits
    • Product list as pdf-file
  • Clostridium
    difficile
    • Clostridium difficile
    • Our expertise
    • Portfolio
      • Antibodies
      • Diagnostic assays
      • Clostridium difficile strains
      • GDH
      • PCR technology
      • Ribotyping
      • Sera
      • Toxins
  • Contract research and development
    • Services
    • Outsourcing
  • EU research projects
  • Hyperdiff
  • Eurotransbio
  • ZIM

Hyperdiff

  • Alle Seiten
    • About tgcBIOMICS
      • Advisory board and management
      • Our team
    • Antibodies
    • Approach
    • Clostridium difficile
      • Clostridium difficile
      • Our expertise
      • Portfolio
        • Clostridium difficile strains
        • Antibodies
        • Diagnostic assays
        • GDH
        • PCR technology
        • Ribotyping
        • Sera
        • Toxins
    • Company profile
    • Contact
      • Contact people
    • Contract research and development
      • Outsourcing
      • Services
    • Downloads
    • ELISA kits
    • EU research projects
      • Eurotransbio
      • Hyperdiff
      • ZIM
    • Imprint
      • Legal notice
    • Job offers
    • NEWS & Press
      • News
    • Our products
      • Antibodies, toxins, proteins, and ELISA kits
      • Product list as pdf-file
    • Patentportfolio
      • List of tgcBIOMICS Patents
    • Proteins
    • Publications
    • Sitemap
    • tgcBIOMICS Technology
      • Bacterial expression system
      • tgc bacteria
      • tgc technology
    • Toxins
    • Welcome to tgcBIOMICS!
  • EU-Project Hyperdiff

    A european research project dealing with detection of hypervirulent strains of Clostridium difficile and the therapy of an infection with this important bacterium.

    Main focus is the inactivation of genes responsible for virulence as well as the development of new methods for the diagnosis of hypervirulent strains.

    More informations on:

    www.clostridia.net